chr9-37015163-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS1
The NM_016734.3(PAX5):c.244G>A(p.Val82Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000162 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 0 hom. )
Consequence
PAX5
NM_016734.3 missense
NM_016734.3 missense
Scores
3
11
5
Clinical Significance
Conservation
PhyloP100: 7.91
Publications
6 publications found
Genes affected
PAX5 (HGNC:8619): (paired box 5) This gene encodes a member of the paired box (PAX) family of transcription factors. The central feature of this gene family is a novel, highly conserved DNA-binding motif, known as the paired box. Paired box transcription factors are important regulators in early development, and alterations in the expression of their genes are thought to contribute to neoplastic transformation. This gene encodes the B-cell lineage specific activator protein that is expressed at early, but not late stages of B-cell differentiation. Its expression has also been detected in developing CNS and testis and so the encoded protein may also play a role in neural development and spermatogenesis. This gene is located at 9p13, which is involved in t(9;14)(p13;q32) translocations recurring in small lymphocytic lymphomas of the plasmacytoid subtype, and in derived large-cell lymphomas. This translocation brings the potent E-mu enhancer of the IgH gene into close proximity of the PAX5 promoter, suggesting that the deregulation of transcription of this gene contributes to the pathogenesis of these lymphomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]
PAX5 Gene-Disease associations (from GenCC):
- leukemia, acute lymphoblastic, susceptibility to, 3Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Broad Center for Mendelian Genomics
- PAX5-related B lymphopenia and autism spectrum disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
PM1
In a DNA_binding_region Paired (size 126) in uniprot entity PAX5_HUMAN there are 7 pathogenic changes around while only 1 benign (88%) in NM_016734.3
BP4
Computational evidence support a benign effect (MetaRNN=0.017112374).
BP6
Variant 9-37015163-C-T is Benign according to our data. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37015163-C-T is described in CliVar as Benign. Clinvar id is 134999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000105 (16/152192) while in subpopulation AMR AF = 0.00105 (16/15274). AF 95% confidence interval is 0.000657. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152192Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000915 AC: 230AN: 251484 AF XY: 0.000589 show subpopulations
GnomAD2 exomes
AF:
AC:
230
AN:
251484
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000168 AC: 246AN: 1461832Hom.: 0 Cov.: 31 AF XY: 0.000124 AC XY: 90AN XY: 727222 show subpopulations
GnomAD4 exome
AF:
AC:
246
AN:
1461832
Hom.:
Cov.:
31
AF XY:
AC XY:
90
AN XY:
727222
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33478
American (AMR)
AF:
AC:
244
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1111958
Other (OTH)
AF:
AC:
1
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000105 AC: 16AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
16
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74362
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41440
American (AMR)
AF:
AC:
16
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5206
South Asian (SAS)
AF:
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68038
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
85
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1Other:1
Mar 10, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population
- -
not provided Benign:1
Nov 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;M;M;.;.;M;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N;N;N;N
REVEL
Pathogenic
Sift
Benign
D;D;D;T;T;D;D;D
Sift4G
Uncertain
D;T;D;T;T;D;D;T
Polyphen
P;.;.;B;P;.;.;.
Vest4
MutPred
Loss of ubiquitination at K79 (P = 0.1647);Loss of ubiquitination at K79 (P = 0.1647);Loss of ubiquitination at K79 (P = 0.1647);Loss of ubiquitination at K79 (P = 0.1647);Loss of ubiquitination at K79 (P = 0.1647);Loss of ubiquitination at K79 (P = 0.1647);Loss of ubiquitination at K79 (P = 0.1647);Loss of ubiquitination at K79 (P = 0.1647);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.